Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.24.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenues:    
Total revenues, net $ 1,924 $ 18,051
Operating expenses:    
Cost of product sales 1,284 3,434
Research and development 13,784 31,308
Selling, general and administrative 10,300 20,711
Goodwill impairment 3,907 0
Amortization expense 0 38
Total operating expenses 29,275 55,491
Operating income (loss) (27,351) (37,440)
Other expense:    
Interest expense, net (3,417) (4,170)
Change in fair value of derivative liability (720) 0
Other expense, net (42) (20)
Total other expense, net (4,179) (4,190)
Loss before income taxes (31,530) (41,630)
Income tax expense 14 28
Net loss $ (31,544) $ (41,658)
Net loss per share of common stock, basic (in dollars per share) [1] $ (114) $ (1,063)
Net loss per share of common stock, diluted (in dollars per share) [1] $ (114) $ (1,063)
Product revenue, net    
Revenues:    
Total revenues, net $ 1,408 $ 3,364
License and other revenue    
Revenues:    
Total revenues, net $ 516 $ 14,687
[1] Amounts for prior periods presented have been retroactively adjusted to reflect the 1-for-240 reverse stock split effected on December 28, 2023. See Note 1 for details.